Virtus ETF Advisers’s Loxo Oncology, Inc LOXO Stock Holding History

Virtus ETF Advisers’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,322	Closed	-$605K	–	304
2018 Q4	$605K	Buy	4,322 +1,684	+64%	+$256K	0.1%	42
2018 Q3	$451K	Sell	2,638 -1,897	-42%	-$319K	0.05%	140
2018 Q2	$787K	Sell	4,535 -4,811	-51%	-$723K	0.7%	39
2018 Q1	$1.08M	Buy	9,346 +4,922	+111%	+$524K	0.94%	30
2017 Q4	$372K	Buy	4,424 +11	+0.2%	+$917	0.47%	70
2017 Q3	$407K	Buy	4,413 +404	+10%	+$31.4K	0.05%	107
2017 Q2	$321K	Sell	4,009 -6,399	-61%	-$355K	0.05%	106
2017 Q1	$438K	Buy	10,408 +997	+11%	+$41.1K	0.08%	109
2016 Q4	$302K	Sell	9,411 -820	-8%	-$21K	0.09%	110
2016 Q3	$268K	Hold	10,231	–	–	0.13%	117
2016 Q2	$237K	Buy	10,231 +1,519	+17%	+$37.8K	0.18%	107
2016 Q1	$238K	Sell	8,712 -546	-6%	-$11.4K	0.33%	66
2015 Q4	$263K	Buy	+9,258	New	+$248K	0.72%	59

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Virtus ETF Advisers's LOXO Position: Q1 2019 in Review

Virtus ETF Advisers sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 4,322 shares — an estimated $605K sold.

Virtus ETF Advisers first reported a position in LOXO in Q4 2015 and held it in 13 quarters. The position peaked at $1.08M in Q1 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Virtus ETF Advisers reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Virtus ETF Advisers sold 4,322 Loxo Oncology, Inc shares in Q1 2019, an estimated $605K.
Virtus ETF Advisers first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 13 quarters.
Virtus ETF Advisers's Loxo Oncology, Inc position peaked at $1.08M in Q1 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Virtus ETF Advisers's 13F filing for Q1 2019, filed 14 May 2019.